Evidence map›Paper›PMID 42564245›Full record

ArticleFrontiers in immunology2026

Extracellular vesicles from cytokine-treated human pancreatic ductal cells enhance HLA class I expression in beta cells.

Neslihan Erdem, Heather N Zook, Janine C Quijano, Nathaniel P Hansen, Joanna Palade, Eunjin Oh, Jacob Mares, Cecile Donohue, Jose A Ortiz, Kevin Jou and 10 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Neslihan ErdemDepartment of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA, United States.
Heather N ZookDepartment of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA, United States.
Janine C QuijanoDepartment of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA, United States.
Nathaniel P HansenIntegrated Mass Spectrometry Shared Resource, City of Hope National Medical Center, Duarte, CA, United States.
Joanna PaladeEarly Detection and Prevention Division, Translational Genomics Research Institute, Phoenix, AZ, United States.
Eunjin OhDepartment of Molecular and Cellular Endocrinology, Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA, United States.
Jacob MaresDepartment of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA, United States.
Cecile DonohueDepartment of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA, United States.
Jose A OrtizDepartment of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA, United States.
Kevin JouDepartment of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA, United States.
Min TalleyDepartment of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA, United States.
Nagesha Guthalu KondegowdaDepartment of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA, United States.
David Arribas-LaytonDepartment of Immunology and Theranostics, Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA, United States.
Rupangi C VasavadaDepartment of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA, United States.
Enrique MonteroDepartment of Diabetes Immunology, Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA, United States.
Helena ReijonenIrell and Manella Graduate School of Biological Sciences, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, United States.
Debbie C ThurmondDepartment of Molecular and Cellular Endocrinology, Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA, United States.
Patrick PirrotteIntegrated Mass Spectrometry Shared Resource, City of Hope National Medical Center, Duarte, CA, United States.
Tijana Jovanovic-TalismanDepartment of Cancer Biology and Molecular Medicine, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, United States.
Hsun Teresa KuDepartment of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA, United States.

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI John Charles Williams · 1985 to 2026
$86.3M
Role of trefoil factor family proteins in beta cell function.R01DK134652 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI Patrick T. Fueger, Hsun Teresa Ku · 2023 to 2026
$2.2M
EX VIVO DIFFERENTIATION AND EXPANSION OF ADULT PANCREATIC COLONY-FORMING UNITSR01DK099734 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI KU, HSUN TERESA · 2014 to 2018
$1.9M
Circulating Extracellular Vesicles in the Pathogenesis of Type 1 DiabetesR01DK125856 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI SAHOO, SUSMITA, VASAVADA, RUPANGI C · 2021 to 2024
$1.8M
Fractionation, Purification and Characterization of Adult Pancreatic Colony-Forming Progenitor CellsR56DK099734 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI KU, HSUN TERESA · 2019 to 2019
$132k
NCI NIH HHS P30 CA033572NIDDK NIH HHS R01 DK099734NIDDK NIH HHS R01 DK125856NIDDK NIH HHS R01 DK134652NIDDK NIH HHS R56 DK099734
6 · The paper itself

Abstract

Introduction/objective: Type 1 diabetes (T1D) is an autoimmune disease characterized by the loss of insulin-producing beta cells and has no cure. The role of cell-cell interactions in T1D disease progression remains poorly understood. Beta cells develop adjacent to ductal cells and both cell types undergo changes during T1D progression, suggesting a potential intercellular communication. Extracellular vesicles (EVs) are established mediators of intercellular communication, but whether human ductal cells secrete EVs that influence beta cells remains unknown. We hypothesize that exposure of human ductal cells to T1D-associated cytokines alters their EV cargo and that EVs produced by cytokine-exposed human ductal cells modulate gene and protein expression in beta cells. Methods: Human exocrine tissues from non-diabetic cadaveric donors were cultured in a 3D suspension to support ductal cell survival. Cells were treated with TNF-α, IL-1β, and IFN-γ or vehicle control for 48 hours and analyzed for proinflammatory-related gene expression and viability by qRT-PCR and Trypan blue exclusion, respectively. EVs from cytokine- and vehicle-treated ductal cells were isolated using size exclusion chromatography and characterized by dot blot, transmission electron microscopy, and nanoparticle tracking analysis. The effects of EVs on EndoC-βH1 human beta cells were assessed with qRT-PCR, RNA-sequencing, and flow cytometry; the effects of EVs on primary human beta cells were assessed with immunofluorescence microscopy. EV cargo was analyzed by proteomics and transcriptomics. Results: EVs from cytokine-treated ductal cells were internalized by EndoC-βH1 beta cells, and compared to control ductal EVs, increased HLA Class I gene and protein expression in EndoC-βH1 cells. In primary human beta cells, EVs from cytokine-treated ductal cells, compared to control ductal EVs, also increased expression of HLA Class I. EV cargo from cytokine-treated versus control ductal cells was enriched for transcripts associated with inflammatory and antigen-presentation-related pathways, including Conclusion: Exposure of T1D-associated cytokines to primary human ductal cells altered cargo of secreted EVs. EVs from cytokine-treated ductal cells upregulated HLA Class I expression in EndoC-βH1 and primary human beta cells. Our results suggest a previously unknown ductal cell communication pathway with a potential implication for modulating beta cells during T1D progression.

Indexed as

CytokinesExtracellular VesiclesHistocompatibility Antigens Class IInsulin-Secreting CellsPancreatic DuctsCell CommunicationCells, CulturedHumansCytokinesHistocompatibility Antigens Class Iductal cellsextracellular vesiclesHLA class Ihuman pancreasproinflammatory cytokines

Identifiers

PMID42564245
PMCPMC13442403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.